Analysts Say These 3 Stocks Are Their Top Picks for 2021
The next company on our list, AlloVir, is another cutting-edge biotech firm. AlloVir’s focus is the development of allogenic, off-the-shelf virus-specific T-cell candidates. These are drugs specifically designed to prevent or treat viral infections in immunocompromised patients with T-cell deficiencies – and limited treatment options.
DA: 29 PA: 94 MOZ Rank: 97 Up or Down: Up